Get started
Author

Linh Hoang

OpenAlex ID: A5109602575
Supplementary Table 8 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 4 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 1 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 5 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 9 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Figure 1 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 7 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Figure 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Figure 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 6 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Figure 3 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
PDF
Supplementary Table 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 9 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 4 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 6 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 7 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 1 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Table 5 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Figure 2 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
PDF
Supplementary Table 8 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Supplementary Figure 1 from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
PDF
Data from Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Therapeutic Vulnerabilities
2023 · David W. Craig, Joyce A. O'Shaughnessy, et al.
Works count: 26
Citation count:
H-index:
I10-index:
Year
Topic
Type